Yikai Yu
- Molecular Biology
- Infectious Diseases
- Rheumatology top 10%
- Pulmonary and Respiratory Medicine
- Physiology
- Topics
- Systemic Lupus Erythematosus Research (4 papers)COVID-19 Clinical Research Studies (3 papers)T-cell and B-cell Immunology (3 papers)
- Journals
- The LancetNature CommunicationsSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yikai Yu
19 papers receiving 365 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 93
- Infectious Diseases 93
- Rheumatology 85
- Pulmonary and Respiratory Medicine 62
- Physiology 58
Countries citing papers authored by Yikai Yu
This map shows the geographic impact of Yikai Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yikai Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yikai Yu more than expected).
Fields of papers citing papers by Yikai Yu
This network shows the impact of papers produced by Yikai Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yikai Yu. The network helps show where Yikai Yu may publish in the future.
Co-authorship network of co-authors of Yikai Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Yikai Yu. A scholar is included among the top collaborators of Yikai Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yikai Yu. Yikai Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 15 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 23 | |
| 6 | 4 | |
| 7 | 68 | |
| 8 | 44 | |
| 9 | 82 | |
| 10 | The presence of P2RX7 single nuclear polymorphism is associated with a gain of function in P2X7 receptor and inflammasome activation in SLE complicated with pericarditis. | 16 |
| 11 | 0 | |
| 12 | Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials. | 8 |
| 13 | 13 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 5 | |
| 17 | 40 | |
| 18 | 13 | |
| 19 | 15 | |
| 20 | 2 |
About Yikai Yu
Yikai Yu is a scholar working on Nephrology, Rheumatology and Hematology, having authored 21 papers that have together received 370 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), COVID-19 Clinical Research Studies (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Rheumatology (85 citations), Infectious Diseases (93 citations) and Hematology (44 citations). Yikai Yu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shaoxian Hu, Yujie Dai, Weina Wang, Cong Ye, Guifen Shen, Lingli Dong, Min Liu, Wei Tu, Xuefen Wu and Yú Chen. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.